Inventor · disambiguated record
Nobuo Hanai
Also filed as: HANAI NOBUO
82 granted patents·14 pending applications·3,367 citations·filing 1987–2019
99Inventor score
Files withKYOWA HAKKO KOGYO KK59KYOWA HAKKO KIRIN CO LTD27KANDA YUTAKA5SHITARA KENYA2BIOMEMBRANE INST1
Top patents by PatentIndex Score
96 records- 0199US7214775B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KOGYO KK·Filed 2005·Granted May 8, 2007·363 cites·7 claims
- 0299US5866692AProcess for producing humanized chimera antibodyKYOWA HAKKO KOGYO KK·Filed 1995·Granted Feb 2, 1999·323 cites·2 claims
- 0398US7737325B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 15, 2010·55 cites·14 claims
- 0498US7708992B2Methods for producing antibody compositions with increased ADCCKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted May 4, 2010·51 cites·16 claims
- 0598US7651688B2Method of modulating the activity of functional immune molecules to CD52KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jan 26, 2010·47 cites·3 claims
- 0698US7425446B2Antibody composition-producing cellKYOWA HAKKO KOGYO KK·Filed 2005·Granted Sep 16, 2008·93 cites·6 claims
- 0798US7393683B2Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferaseKYOWA HAKKO KOGYO KK·Filed 2005·Granted Jul 1, 2008·63 cites·6 claims
- 0898US6946292B2Cells producing antibody compositions with increased antibody dependent cytotoxic activityKYOWA HAKKO KOGYO KK·Filed 2001·Granted Sep 20, 2005·566 cites·12 claims
- 0997US8067232B2Antibody composition-producing cell with inactivated A-1,6-fusocyltransferaseKANDA YUTAKA·Filed 2008·Granted Nov 29, 2011·45 cites·5 claims
- 1097US7846725B2Antibody composition-producing cell in which enzyme expression is inhibited by RNAiKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Dec 7, 2010·35 cites·6 claims
- 1197US7741442B2Antibody composition exhibiting increased cellular cytotoxicity due to glycosylationKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 22, 2010·32 cites·4 claims
- 1297US7718175B2Method of modulating the activity of functional immune molecules to interleukin-5 receptor proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 18, 2010·32 cites·3 claims
- 1397US7687061B2Method of modulating the activity of functional immune molecules to Her-2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 30, 2010·29 cites·3 claims
- 1497US7682610B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·33 cites·3 claims
- 1597US5750078AProcess for producing humanized chimera antibodyKYOWA HAKKO KOGYO KK·Filed 1995·Granted May 12, 1998·156 cites·3 claims
- 1696US7763246B2Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptorKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jul 27, 2010·23 cites·3 claims
- 1796US7708997B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 4, 2010·24 cites·3 claims
- 1896US7682611B2Method of modulating the activity of functional immune molecules to CXCR4 proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·26 cites·3 claims
- 1996US7655228B2Method of modulating the activity of functional immune molecules to GM2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Feb 2, 2010·24 cites·3 claims
- 2096US6989145B2Recombinant antibody and antibody fragmentKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jan 24, 2006·93 cites·37 claims
- 2196US6018032AAntibody against human interleukin-5-receptor α chainKYOWA HAKKO KOGYO KK·Filed 1996·Granted Jan 25, 2000·146 cites·13 claims
- 2295US6437098B1Human chimeric antibody specific for the ganglioside GD3KYOWA HAKKO KOGYO KK·Filed 1999·Granted Aug 20, 2002·87 cites·4 claims
- 2393US7709234B2α-1,3-fucosyltransferaseKYOWA HAKKO KIRIN CO LTD·Filed 2006·Granted May 4, 2010·21 cites·7 claims
- 2493US7666418B2Method for treating Th2-mediated diseaseKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Feb 23, 2010·22 cites·32 claims
- 2593US6986890B1Anti-human VEGF receptor Flt-1 monoclonal antibodyKYOWA HAKKO KOGYO KK·Filed 1999·Granted Jan 17, 2006·100 cites·6 claims
- 2693US6872392B2Humanized antibodiesKYOWA HAKKO KOGYO KK·Filed 2002·Granted Mar 29, 2005·44 cites·3 claims
- 2793US5830470AHumanized antibodies to ganglioside GM2KYOWA HAKKO KOGYO KK·Filed 1993·Granted Nov 3, 1998·112 cites·3 claims
- 2892US8039595B2Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Oct 18, 2011·9 cites·5 claims
- 2991US7253263B1Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3KYOWA HAKKO KOGYO KK·Filed 2000·Granted Aug 7, 2007·37 cites·12 claims
- 3090US8679491B2Method of modulating the activity of functional immune moleculesHANAI NOBUO·Filed 2009·Granted Mar 25, 2014·12 cites·2 claims
- 3190US7238354B2Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chainKYOWA HAKKO KOGYO KK·Filed 2005·Granted Jul 3, 2007·11 cites·37 claims
- 3290US7052693B2Anti-human VEGF receptor FLT-1 monoclonal antibodyKYOWA HAKKO KOGYO KK·Filed 2002·Granted May 30, 2006·20 cites·8 claims
- 3389US8101185B2Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylationKANDA YUTAKA·Filed 2010·Granted Jan 24, 2012·6 cites·4 claims
- 3489US7438911B2Antibody against human insulin-like growth factorKYOWA HAKKO KOGYO KK·Filed 2003·Granted Oct 21, 2008·33 cites·13 claims
- 3588US6103236AToxin conjugatesKYOWA HAKKO KOGYO KK·Filed 1996·Granted Aug 15, 2000·79 cites·11 claims
- 3687US8895266B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2012·Granted Nov 25, 2014·4 cites·4 claims
- 3787US8158760B2Glycoengineered, recombinant antibodyKANDA YUTAKA·Filed 2009·Granted Apr 17, 2012·4 cites·4 claims
- 3886US8329443B2Antibody composition-producing cellKANDA YUTAKA·Filed 2011·Granted Dec 11, 2012·4 cites·4 claims
- 3986US8110195B2Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibodyKANDA YUTAKA·Filed 2010·Granted Feb 7, 2012·4 cites·4 claims
- 4086US7179464B2Method of treatment by administering an antibody to human interleukin-5 receptor α chainKYOWA HAKKO KOGYO KK·Filed 2002·Granted Feb 20, 2007·16 cites·35 claims
- 4186US5807548AMethod of treating cancer using a chimera antibodyKYOWA HAKKO KOGYO KK·Filed 1995·Granted Sep 15, 1998·30 cites·1 claims
- 4283US10233247B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Mar 19, 2019·2 cites·6 claims
- 4382US8632996B2Method for producing recombinant antibody and antibody fragment thereofSHITARA KENYA·Filed 2012·Granted Jan 21, 2014·4 cites·28 claims
- 4482US4892935AAnti-human pulmonary carcinoma monoclonal antibodyKYOWA HAKKO KOGYO KK·Filed 1987·Granted Jan 9, 1990·47 cites·3 claims
- 4580US6638509B1Toxin conjugatesKYOWA HAKKO KOGYO KK·Filed 2000·Granted Oct 28, 2003·8 cites·4 claims
- 4680US6423511B1Humanized antibodiesKYOWA HAKKO KOGYO KK·Filed 1999·Granted Jul 23, 2002·42 cites·7 claims
- 4780US5494790Aα-3 sialyltransferaseKYOWA HAKKO KOGYO KK·Filed 1994·Granted Feb 27, 1996·55 cites·22 claims
- 4879US8197814B2Method for treating the Th2-mediated diseaseSHITARA KENYA·Filed 2010·Granted Jun 12, 2012·3 cites·32 claims
- 4979US7045129B2Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3KYOWA HAKKO KOGYO KK·Filed 2002·Granted May 16, 2006·2 cites·2 claims
- 5077US7615215B2Anti-human VEGF receptor Flt-1 monoclonal antibodyKYOWA HAKKO KIRIN CO LTD·Filed 2006·Granted Nov 10, 2009·1 cites·9 claims
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nobuo Hanai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →